Skip to content
10-Q

Quarterly Report

GB SCIENCES INC

0001437749-24-036322

← back to feed
Filed
Nov 27, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Nov 27, 2024 407.07M sh
Operating Cash Flow Q1 2025 · Jun 30, 2024 −$21.99K
Operating Cash Flow Q1 2025 · Jun 30, 2023 −$105.3K
Cash And Equivalents Q1 2025 · Jun 30, 2024 $0
Cash And Equivalents Q1 2025 · Mar 31, 2024 $11.99K
Stockholders Equity Q1 2025 · Jun 30, 2024 −$5.59M
Stockholders Equity Q1 2025 · Mar 31, 2024 −$5.31M
Current Liabilities Q1 2025 · Jun 30, 2024 $5.36M
Current Liabilities Q1 2025 · Mar 31, 2024 $5.1M
Total Liabilities Q1 2025 · Jun 30, 2024 $5.68M
Total Liabilities Q1 2025 · Mar 31, 2024 $5.42M
Current Assets Q1 2025 · Jun 30, 2024 $91.45K
Current Assets Q1 2025 · Mar 31, 2024 $103.44K
Eps Basic Q1 2025 · Jun 30, 2024 $0.00
Eps Basic Q1 2025 · Jun 30, 2023 $0.00
Sga Expense Q1 2025 · Jun 30, 2024 $254.14K
Sga Expense Q1 2025 · Jun 30, 2023 $265.12K
Net Income Q1 2025 · Jun 30, 2024 −$285.02K
Net Income Q1 2025 · Jun 30, 2023 −$273.12K
Operating Income Q1 2025 · Jun 30, 2024 −$254.14K
Operating Income Q1 2025 · Jun 30, 2023 −$265.12K
Gross Profit Q1 2025 · Jun 30, 2024 $0
Gross Profit Q1 2025 · Jun 30, 2023 $0
Cost Of Revenue Q1 2025 · Jun 30, 2024 $0
Cost Of Revenue Q1 2025 · Jun 30, 2023 $0
Revenue Q1 2025 · Jun 30, 2024 $0
Revenue Q1 2025 · Jun 30, 2023 $0